A $1B drug substance manufacturing expansion for one of the world’s largest biopharmaceutical companies, with CRB Consulting Engineers as A/E of Record. Stelic has supported this project from concept design through detailed design and construction administration, embedded inside CRB’s design and procurement team as the full-time project controls function — providing cost, schedule, change, and risk support to CRB and the owner across every phase. 

Stelic delivers a Primavera P6 design-phase schedule, cost tracking against authorized fee, weekly and monthly progress reports, risk register management, and change evaluation. Stelic provides bi-weekly schedule updates to both design and procurement teams, maintainingalignment between design progress and procurement sequencing. Stelic also developed and manages an interactive procurement dashboard that tracks the status of each procurement package and the target issuance dates for review, bid, and on-site arrival — giving project managers and the owner’s leadership team a live view of package status, procurement lead times, and schedule exposure at the work-package level. 

Change management was implemented from the outset. Stelic established and manages the change management process, assessing the impact of owner and contractor-driven changes to the base scope and ensuring timely decision-making before schedule and cost exposure compounds. 

For life sciences design teams, a controls function that doesn’t keep pace with design decisions is a liability. Stelic has operated inside CRB’s design process on this project since early 2025 — providing the cost, schedule, change, and risk infrastructure that keeps phase-gate decisions informed and on time. The engagement continues.